3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 4
1
Phase 2/3
1
Status
Completed
5
Recruiting
3
Unknown
1
Terminated
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
NET
2
Gastrointestinal
2
Endocrine
2
Conditions
Neuroendocrine Tumors
2
Rectal Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Anastomotic Leak
1
Interventions
pembrolizumab
555
Specimen Handling
459
Carboplatin
446
Magnetic Resonance Spectroscopy
427
Cyclophosphamide
412
Cisplatin
404
Gemcitabine
314
Radiotherapy
313
Bevacizumab
310
Paclitaxel
300
Biopsy
260
Drug Therapy
252
Capecitabine
241
Oxaliplatin
240
fludarabine
236
Nivolumab
226
venetoclax
225
Injections
214
Docetaxel
203
Fluorouracil
201
Dexamethasone
186
Radiosurgery
172
Rituximab
161
Pemetrexed
157
durvalumab
144
Standard of Care
143
atezolizumab
139
toripalimab
137
tislelizumab
137
Leucovorin
137
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Recruiting
×
Interventional
×
Somatostatin
×
Clear all
NCT07605611
2026-05-26
SC-Stoma
Tongji Hospital
Phase NA
Recruiting
72 enrolled
NCT06855095
2025-03-03
ATSA
The Netherlands Cancer Institute
Phase 2/3
Recruiting
39 enrolled
NCT05701241
2024-06-14
SAUNA
University Hospital, Antwerp
Phase 4
Recruiting
270 enrolled